Dupilumab in Moderate-to-Severe Atopic Dermatitis: Pooled Efficacy Results from Two Identically Designed Randomized Phase 3 Trials (SOLO 1 & 2)
Ferrandiz, Carlos, De la Cueva Dobao, Pablo, Simpson, Eric L, Zhang, Rick, Gadkari, Abjijit, Eckert, Laurent, Akinlade, Bolanle, Ardeleanu, Marius
Published in Skin (Milwood, N.Y.) (27.10.2017)
Published in Skin (Milwood, N.Y.) (27.10.2017)
Get full text
Journal Article